{"symbol":"REGN","fiscalQuarter":"Q1-2009","reportDate":"2009-04-30","reportTime":"BMO","status":"reported","company":{"name":"Regeneron Pharmaceuticals, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/REGN/earnings/Q1-2009","postBrief":{"headline":"Regeneron Pharmaceuticals Misses on EPS, Stock Down 1.63%","keyNumbers":[{"metric":"EPS","actual":"$-0.22","expected":"N/A","surprise":"+24.14%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management noted challenges in the current market environment.","They emphasized a focus on long-term growth despite short-term setbacks."],"summary":"Management expressed caution regarding market conditions and highlighted the importance of strategic investments. They remain focused on future opportunities."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Regeneron's earnings report showed a loss per share that exceeded expectations, which may indicate ongoing challenges for the company. The stock reacted negatively, declining by 1.63%, likely due to concerns over market conditions and the lack of revenue data. Investors will be watching closely for future updates on performance and strategy.","metaDescription":"Regeneron Pharmaceuticals (REGN) Q1 2009 earnings: EPS missed. Stock down 1.63%. Full breakdown."}}